HOPE FOR FIBROIDS

Doctors Info Web Directory

March 2005 OBGYN.net Outstanding Achievement Award presented to Hope For Fibroids Organization.
Fibroid Discussion Forum

Home
Mission
Doctor List
Languages
HFF Updates
Men & Family
Pregnancy
Patient Guides
Just the FAQs
Case/Analysis Comments
Contact Form
Contact Us
Media
Research

Bibliography
Book List
Insurance
Legislation
Other Sources

Site Map


In the News Media

November 19, 2004 Dr. James Spies performed UFE for Ms. Condoleezza Rice's uterine fibroids - Washington, D.C.




 


 

 

 
 
Legislation Reform Needed Update:

Dr. James Spies is the Professor of Radiology at Georgetown University School of Medicine, Chief of Service, Department of Radiology.   He leads the Georgetown Uterine Embolization Program and serves as Vice Chairman of Radiology.   His particular research interests include the outcome of uterine fibroid embolization and measuring health outcomes in interventional radiology.  E-mail address:  spiesj@gunet.georgetown.edu

"I want to thank Dr. Spies for allowing Hope For Fibroids, Inc. permission to publish the following Bibliography.   The research information will help women and their families.   Thank You." - Hope Waltman

Research

  1. Spies JB, Scialli, AR, Jha RC, Imaoka I, Ascher S, Fraga VM, Barth, KH. “Initial Results From Uterine Fibroid Embolization for Symptomatic Leiomyomata.”  J Vasc Interv Radiol 1999;10:1149-1157.
  2. Spies JB, Warren E, Mathias S, Walsh SM, Pentecost MJ.  “Measurement of Health-related Quality of Life Before and After Uterine Fibroid Embolization for Symptomatic Leiomyomata.”  J Vasc Interv Radiol 1999;10:1293-1303.
  3. Nikolic B, Spies JB, Lundsten M.  “Patient Radiation Dose Associated With Uterine Artery Embolization for Leiomyomas.”  Radiology 2000;214:121-125.
  4. Roth,  AR, Spies JB Walsh  SM,  Wood, BJ., Gomez-Jorge J, Levy,  EB.  “ Pain After Uterine Artery Embolization for Leiomyomata: Can its Severity be Predicted and Does the Severity Predict Outcome?” J Vasc Interv Radiol 2000; 11:1047-1052.
  5. Jha RC, Ascher SM, Imaoka I, Spies JB.   “Symptomatic Fibroleiomyomata: MR Imaging of the Uterus Before and After Uterine Arteral Embolization.”  Radiology 2000;217:228-235.
  6. Nikolic B, Abbara S, Levy EB, Lundsten M, Spies JB.  “ Influence of Technique and Equipment on Absorbed Ovarian Dose Associated With Uterine Embolization.”  J Vasc Interv Radiol 2000;11:1173-1178.
  7. Nikolic B, Spies JB, Campbell L, Walsh SM, Abbara S, Lunndsten MJ.   “Patient Radiation Dose Associated With Uterine Artery Embolization for Leiomyomata: Reduced Dose Using a Refined Technique.” J Vasc Interv Radiol 2001;12:39-44.
  8.

Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch R, Lipman J, Machan L, Sacks D, Sterling K, Lewis C; Task force on Uterine Artery Embolization. Standards Division of Society of Cardiovascular & Interventional Radiology. Training standards for physicians performing uterine artery embolization for leiomyomata: consensus statement developed by the Task Force on Uterine Artery Embolization and the standards division of the Society of Cardiovascular & Interventional Radiology--August 2000.  J Vasc Interv Radiol. 2001 Jan;12(1):19-21. (PubMed)

  9. Worthington-Kirsch R, Fueredi G, Goodwin S, Machan L, Niedzwiecki G, Reidy J, Spies J, Walker W. Polyvinyl alcohol particle size for uterine artery embolization.  Radiology. 2001 Feb;218(2):605-6. (PubMed)
10. Spies JB, Roth, AR, Gonsalves, SM, Murphy-Skrzyniarz, KM.   “Ovarian Function After Uterine Artery Embolization: Assessment Using Serum Follicle-stimulating Hormone Assay.”  J Vasc Interv Radiol 2001;12:437-442.
11. Subramanian S, Spies JB.   “Uterine Artery Embolization for Leiomyomata: Resource Use and Cost Estimation.”  J Vasc Interv Radiol 2001;12:571-574.
12. Spies JB, Ascher SA, Roth AR, Kim J, Levy EB, Gomez-Jorge J.  “Uterine Artery Embolization for Leiomyomata.”   Obstetrics and Gynecology 2001;98:29-34.
13. Keyoung JA,  Levy EB,  Roth AR,  Gomez-Jorge J,  Chang TC, Spies JB“ Initial Experience With Intra-arterial Lidocaine in Controlling Pain After Uterine Artery Embolization for Leiomyomata.”   J Vasc Intervent Radiol 2001;12:1065-1069.
14. Spies JB, Benenati JF, Worthington-Kirsch, R, Pelage, JP.   “Initial U.S. Experience UsingTris-acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomata.”  J Vasc Intervent Radiol 2001;12:1059-1063.
15. Spies JB, Roth, AR, Jha RC, Gomez-Jorge J, Levy EB, Chang TC, Ascher SA.   “Uterine Artery Embolization for Leiomyomata: Factors Associated With Successful Symptomatic and Imaging Outcome.”  Radiology 2002;222:45-52.
16. Spies JB, Coyne K, Guaou Guaou N, et al.  “The UFS-QOL, a New Disease-specific Symptom and Health-related Quality of Life Questionnaire for Leiomyomata.”  Obstet and Gynecol 2002; 99:290-300.
17. Banovac  FB,  Ascher  SM,  Jones DA,  Black MD,  Smith JC, Spies JB.  “ MR Imaging Outcome After Uterine Artery Embolization for Leiomyomata Using Tris-Acryl Gelatin Microspheres.”  J Vasc Intervent Radiol, 2002;  13:681-687.
18. Spies JB, Spector A, Roth AR, Baker CM., Mauro L, Murphy-Skrynarz, K.  “Complications After Uterine Artery Embolization for Leiomyomata.”  Obstetrics and Gynecology 2002;100:873-80.
19. Baker CM, Winkel CA, Subramanian S, Spies JB.   “Estimated Costs for Uterine Artery Embolization and Abdominal Myomectomy for Uterine Leiomyomata: A Comparative Study at a Single Institution.” J Vasc Invent Radiol 2002; 13:1207-1210.
20. Jha, RC, Tkahama, J, Imaoka, I, Korangy, SJ, Spies JB, Cooper C, Ascher SM.   “Adenomyosis: MRI of the Uterus Treated With Uterine Artery Embolization.”  AJR 2003;181:851-856.
21. Nikolic B, Kessler C, Jacobs H,Abbara S,  Ammann A, Neeman, Z McCullough M, Martinez H, Spies JB “Changes in Blood Coagulation Markers Associated With Uterine Artery Embolization for Leiomyomata.”  J Vasc Intervent Radiol 2003; 14:1147-1153.
22. Barth M, Spies JB.   “Ovarian Embolization Supplementing Uterine Embolization for Leiomyomata.” J Vasc Intervent Radiol 2003; 14:1177-1182.
23. Gomez-Jorge J, Keyoung A, Levy EB, Spies JB.   “Uterine Artery Anatomy Relevant to Uterine Leiomyomata Embolization.”  Cardiovasc Intervent Radiol 2003; 26:522-527.
24. Spies J, Niedzwiecki G, Goodwin S, Patel N, Andrews R, Worthington-Kirsch R, Lipman J, Machan L, Sacks D, Sterling K, Lewis C; Task Force on Uterine Artery Embolization; Standards Division of the Society of Interventional Radiology. Training standards for physicians performing uterine artery embolization for leiomyomata. Consensus statement developed by the Task Force on Uterine Artery Embolization and the Standards Division of the Society of Interventional Radiology--August 2000. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S369-71(PubMed)
25. Pelage JP, Guaou Guaou N, Jha RC, Ascher SM, Spies JB.  “Long-term Imaging Outcome After Uterine Embolization for Fibroids.”  Radiology2004;230:803-809.
26. Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF.   “Outcome From Uterine Embolization and Hysterectomy for Leiomyomas: Results of a Multi-center Study.” American Journal of Obstetrics and Gynecology 2004;191:22-31.
27. Spies JB, Allison S, Flick P, McCullough M, Sterbis K, Cramp M, Bruno J, Jha RC.   “Polyvinyl Alcohol Particles and Tris-acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomas:Results of a Randomized Comparative Study.”  J Vasc Intervent Radiol  2004;15;793-800.
28. Bruno J, Sterbis K, Flick P,McCullough M, Cramp M, Murphy-Skyrnarz K, Spies JB.   “Recovery After Uterine Artery Embolization for Leiomyomas:  A Detailed Analysis of  its Duration and Severity.”  J Vasc Intervent Radiol 2004;15:801-807.
29. Spies, JB.;   UFE Five-Year follow-up 182 of 200 patients shows Interventional Radiology procedure is durable:  "Long-Term Data Show Uterine Fibroid Embolization Is Effective Treatment for Uterine Fibroids" - Released April 1, 2005 (SIR)
30. Andrews RT, Spies JB, Sacks D, Worthington-Kirsch RL, Niedzwiecki GA, Marx MV, Hovsepian DM, Miller DL, Siskin GP, Raabe RD, Goodwin SC, Min RJ, Bonn J, Cardella JF, Patel NH. “Patient Care and Uterine Artery Embolization for Leiomyomata”,  National Guideline Clearinghouse;  J Vasc Interv Radiol 2004 Feb;15(2 Pt 1):115-20. (PubMed) http://www.guidelines.gov/summary/summary.aspx?view_id=1&doc_id=5394
31. Golzarian J, Lang E, Hovsepian D, Kroncke T, Lampmann L, Lohle P, Pelage JP, Shlansky-Goldberg R, Valenti D, Vorwerk D, Spies J. “Higher rate of partial devascularization and clinical failure after uterine artery embolization for fibroids with spherical polyvinyl alcohol”.  Cardiovasc Intervent Radiol. 2006 Jan-Feb;29(1):1-3. (PubMed)

Legal Note:
  The material presented on Hope For Fibroids, Inc. web site is for informational purposes only.  It is not meant to be a substitute for physician care. 
If you need medical advice on uterine fibroid disease or other medical conditions you should discuss them with a physician.

Last modified:  Monday January 01, 2007
Copyright  2005-2007    Hope For Fibroids Inc.
(web site designed & developed by Hope)      

 

James B. Spies, M.D. is an Interventional Radiologist at Georgetown University School of Medicine, Washington, D.C.  He performs Uterine Fibroids Embolization for uterine fibroids.

James B. Spies, M.D.

Professor of Radiology
Chief of Service, Department of Radiology, CG 201
3800 Reservoir Rd. NW
Washington, DC 20007-2113
Phone (202) 444-5478
Fax (202) 444-4899
Map to Dr. Spies Office
UAE Illustration
FAQS Listing #1

FAQS Listing #2

FAQS Listing #3
 

Hope For Fibroids Poster (PDF)

To download Adobe Reader